Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice?

被引:0
|
作者
Demirbag, Ali E. [1 ]
Turhan, Nesrin [2 ]
Ercis, Serpil [3 ]
Hamaloglu, Erhan [4 ]
机构
[1] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Gastrointestinal Surg, Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Pathol, Ankara, Turkey
[3] Hacettepe Univ, Sch Med, Dept Microbiol & Clin Microbiol, Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Gen Surg, Ankara, Turkey
关键词
GM-CSF; obstructive jaundice; surgical trauma; bacterial translocation; Kupffer cell; GUT BARRIER FUNCTION; INTESTINAL PERMEABILITY; INCREASES BACTERIAL; CONTROLLED-TRIAL; FAILURE; ENDOTOXIN; BLOOD; DYSFUNCTION; ACTIVATION; MICE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: The incidence of sepsis can be decreased by preventing bacterial translocation, as the first step in enhanced host defense. The aim of this study was to prevent translocation and to increase Kupffer cell incidence by using granulocyte-macrophage colony-stimulating factor in rats with surgical trauma and obstructive jaundice. Methods: Seventy-five Sprague-Dawley rats were randomized into 8 groups. After calibration of laboratory conditions by Group 0, SHAM operations in Groups I, H, HA and common bile duct ligations in Groups III, IV, IVA and V were performed. Granulocyte-macrophage colony-stimulating factor doses were 6 mu g/kg/d in Groups II, IV; 1 mu g/kg/d in HA, IVA postoperatively; and 6 mu g/kg/d in Group V preoperatively, for 7 days. After one week, all rats were reoperated for cecal lymph node, liver and spleen biopsies for culture and histopathology. All culture specimens were identified as positive/negative/contaminated. Survivals were recorded, and after the 21(st) day surviving rats were sacrificed by decapitation. Results: There was no translocation in Group 0 in the three specimens of liver, cecal lymph node and spleen. Group V showed minimal (10%) positivity in only liver, and othergroups ranged between 20-70% in cecal lymph node, liver and spleen tissues, respectively (p<0.05). Kupffer cell incidences were higher in the granulocyte-macrophage colony-stimulating factor given groups than in controls, and lower in common bile duct ligation groups than in SHAM groups (p<0.001). Groups 0 and V showed the best (median 20 days) and Group III the worst (methan 11.7 days) survival (p<0.001). Conclusions: Not only surgical trauma but also obstructive jaundice caused high incidence of translocation, decreased number of Kupffer cells and shortened survival. Translocation ratios were decreased by granulocyte-macrophage colony-stimulating factor in the SHAM and common bile duct ligation groups. Granulocyte-macrophage colony-stimulating factor prevented the decrease in Kupffer cell incidence caused by jaundice and prolonged the survival by preventing translocation at the first step.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [41] Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes
    Suzuki, H
    Katayama, N
    Ikuta, Y
    Mukai, K
    Fujieda, A
    Mitani, H
    Araki, H
    Miyashita, H
    Hoshino, N
    Nishikawa, H
    Nishii, K
    Nobuyuki, M
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (04) : 179 - 189
  • [42] INCREASED RESPIRATORY BURST ACTIVITY OF NEUTROPHILS IN PATIENTS WITH APLASTIC-ANEMIA - EFFECTS OF GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    OHSAKA, A
    KITAGAWA, S
    YUO, A
    MOTOYOSHI, K
    OHTA, M
    MIURA, Y
    TAKAKU, F
    SAITO, M
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (09) : 1090 - 1093
  • [43] DRUG-INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    HURTADO, R
    CANDELARIA, M
    MAJLUFCRUZ, A
    SOSACAMAS, RE
    LABARDINIMENDEZ, J
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1994, 46 (01): : 59 - 61
  • [44] Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients
    Page, Andrea V.
    Liles, W. Conrad
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (06) : 575 - 580
  • [45] Effect of intranasal administration of Granulocyte-Macrophage Colony-Stimulating Factor on pulmonary Cryptococcus gattii infection
    Hansakon, Adithap
    Khampoongern, Rungwadee
    Schiller, Lauritz
    Jeerawattanawart, Siranart
    Angkasekwinai, Pornpimon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [46] Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis
    McNamee, E. N.
    Biette, K. A.
    Hammer, J.
    Harris, R.
    Miyazawa, H.
    Lee, J. J.
    Furuta, G. T.
    Masterson, J. C.
    ALLERGY, 2017, 72 (08) : 1232 - 1242
  • [47] Differential Regulation of Macrophage Glucose Metabolism by Macrophage Colony-stimulating Factor and Granulocyte-Macrophage Colony-stimulating Factor: Implications for 18F FDG PET Imaging of Vessel Wall Inflammation
    Tavakoli, Sina
    Short, John D.
    Downs, Kevin
    Huynh Nga Nguyen
    Lai, Yanlai
    Zhang, Wei
    Jerabek, Paul
    Goins, Beth
    Sadeghi, Mehran M.
    Asmis, Reto
    RADIOLOGY, 2017, 283 (01) : 87 - 97
  • [48] Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice
    Hattori, K
    Orita, T
    Oheda, M
    Tamura, M
    Ono, M
    IN VIVO, 1996, 10 (03): : 319 - 327
  • [49] Granulocyte-macrophage colony-stimulating factor: inhibitor of tumor necrosis factor-induced apoptosis
    Quentmeier, H
    Reinhardt, J
    Zaborski, M
    Drexler, HG
    LEUKEMIA RESEARCH, 2003, 27 (06) : 539 - 545
  • [50] Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers
    Borbolla-Escoboza, JR
    Maria-Aceves, R
    Lopez-Hernandez, MA
    Collados-Larumbe, MT
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1997, 49 (06): : 449 - 451